Cyclosporin A is a selective immunosuppressant, used in organ transplants to prevent graft rejection. Cyclosporin A can cause various side effects including gingival overgrowth. The aim of this work was to evaluate gingival overgrowth of rats treated daily with 10 mg/kg body weight of cyclosporin A for 60 days, as well as the regression after the interruption of treatment. All rats treated with cyclosporin A developed gingival overgrowth, with increased thickness of the epithelium, height and width of the connective tissue. The density of fibroblasts and collagen fibers also increased. Five to 90 days after the interruption of treatment with cyclosporin A, there was a progressive reduction of the gingival volume and of collagen fibers and f...
Gingival overgrowth is a serious side-effect that accompanies the use of cyclosporine. Up to 97% of ...
BACKGROUND: The objective of the present study was to investigate the effect of cyclosporin A (CsA) ...
Cyclosporin A(CsA) is now widely used to treat organ transplant recipients. But CsA has various shor...
Cyclosporin A (CsA) is used as an immunosuppressive agent and its prominent side effect is the induc...
Os aumentos gengivais podem ser decorrentes de reações teciduais a estímulos idiopáticos, patológico...
Abstract Background Drug-induced gingival overgrowth is a frequent adverse effect associated princip...
Background and objective: Gingival overgrowth is one of the side effects of cyclosporine A, an immu...
Background and objective: Gingival overgrowth is one of the side effects of cyclosporine A, an immu...
Background: Cyclosporin A and nifedipine cause gingival overgrowth in rat, and the combined use of t...
Background: Tacrolimus, an immunosuppressive drug used in organ transplantation, has been reported n...
Background: The treatment of cyclosporin A triggers an early bone loss and gingival overgrowth. Ther...
THE INFLUENCE OF CHEMICAL PLAQUE CONTROL, using topically applied 0.12% chlorhexidine, on the severi...
Drug-induced gingival overgrowth may occur after a chronic administration of three classes of system...
Gingival overgrowth is a serious side-effect that accompanies the use of cyclosporine. Up to 97% of ...
Gingival overgrowth can be induced in patients treated with cyclosporine-A (CsA), an immunosuppressa...
Gingival overgrowth is a serious side-effect that accompanies the use of cyclosporine. Up to 97% of ...
BACKGROUND: The objective of the present study was to investigate the effect of cyclosporin A (CsA) ...
Cyclosporin A(CsA) is now widely used to treat organ transplant recipients. But CsA has various shor...
Cyclosporin A (CsA) is used as an immunosuppressive agent and its prominent side effect is the induc...
Os aumentos gengivais podem ser decorrentes de reações teciduais a estímulos idiopáticos, patológico...
Abstract Background Drug-induced gingival overgrowth is a frequent adverse effect associated princip...
Background and objective: Gingival overgrowth is one of the side effects of cyclosporine A, an immu...
Background and objective: Gingival overgrowth is one of the side effects of cyclosporine A, an immu...
Background: Cyclosporin A and nifedipine cause gingival overgrowth in rat, and the combined use of t...
Background: Tacrolimus, an immunosuppressive drug used in organ transplantation, has been reported n...
Background: The treatment of cyclosporin A triggers an early bone loss and gingival overgrowth. Ther...
THE INFLUENCE OF CHEMICAL PLAQUE CONTROL, using topically applied 0.12% chlorhexidine, on the severi...
Drug-induced gingival overgrowth may occur after a chronic administration of three classes of system...
Gingival overgrowth is a serious side-effect that accompanies the use of cyclosporine. Up to 97% of ...
Gingival overgrowth can be induced in patients treated with cyclosporine-A (CsA), an immunosuppressa...
Gingival overgrowth is a serious side-effect that accompanies the use of cyclosporine. Up to 97% of ...
BACKGROUND: The objective of the present study was to investigate the effect of cyclosporin A (CsA) ...
Cyclosporin A(CsA) is now widely used to treat organ transplant recipients. But CsA has various shor...